Rituximab as a second-line treatment for lymphocytic vasculitis of the central nervous system

Saar Anis*, Amir Sharabi, Yair Mina, Ainat Klein, Emanuela Cagnano, Ori Elkayam, Tanya Gurevich

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)630-632
Number of pages3
JournalIsrael Medical Association Journal
Issue number10
StatePublished - Oct 2016


  • Lymphocytic vasculitis
  • Primary central nervous system angiitis
  • Rituximab

Cite this